Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin

Nat Genet. 2023 Nov;55(11):1892-1900. doi: 10.1038/s41588-023-01545-1. Epub 2023 Oct 26.

Abstract

Somatic mutations are hypothesized to play a role in many non-neoplastic diseases. We performed whole-exome sequencing of 1,182 microbiopsies dissected from lesional and nonlesional epidermis from 111 patients with psoriasis to search for evidence that somatic mutations in keratinocytes may influence the disease process. Lesional skin remained highly polyclonal, showing no evidence of large-scale spread of clones carrying potentially pathogenic mutations. The mutation rate of keratinocytes was similarly only modestly affected by the disease. We found evidence of positive selection in previously reported driver genes NOTCH1, NOTCH2, TP53, FAT1 and PPM1D and also identified mutations in four genes (GXYLT1, CHEK2, ZFP36L2 and EEF1A1) that we hypothesize are selected for in squamous epithelium irrespective of disease status. Finally, we describe a mutational signature of psoralens-a class of chemicals previously found in some sunscreens and which are used as part of PUVA (psoralens and ultraviolet-A) photochemotherapy treatment for psoriasis.

MeSH terms

  • Ficusin / therapeutic use
  • Furocoumarins* / therapeutic use
  • Humans
  • Mutation
  • PUVA Therapy
  • Psoriasis* / drug therapy
  • Psoriasis* / genetics
  • Psoriasis* / pathology

Substances

  • Ficusin
  • Furocoumarins